Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein

被引:2
作者
Race, Brent [1 ]
Jeffrey, Martin [2 ]
McGovern, Gillian [2 ]
Dorward, David [3 ]
Chesebro, Bruce [1 ]
机构
[1] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Hamilton, MT 59840 USA
[2] APHA, Lasswade Lab, Bush Loan, Penicuik, Midlothian, Scotland
[3] NIAID, Electron Microscopy Sect, Res Technol Branch, Rocky Mt Labs, Hamilton, MT USA
关键词
Alzheimer disease; amyloid; brown fat; basement membrane; cerebral amyloid angiopathy; CAA; colon; follicular dendritic cells; glycosylphosphatidylinositol; glycosaminoglycan; heart; lymphoid tissues; macrophages; prion protein; spleen; transmissible spongiform encephalopathies; white fat; CREUTZFELDT-JAKOB-DISEASE; CHRONIC WASTING DISEASE; CARDIOMYOPATHY; ANTIBODIES; PHENOTYPE; THERAPY; MOUSE; PRNP; PRP;
D O I
10.1080/19336896.2017.1336274
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In most human and animal prion diseases the abnormal disease-associated prion protein (PrPSc) is deposited as non-amyloid aggregates in CNS, spleen and lymphoid organs. In contrast, in humans and transgenic mice with PrP mutations which cause expression of PrP lacking a glycosylphosphatidylinositol (GPI)-anchor, most PrPSc is in the amyloid form. In transgenic mice expressing only anchorless PrP (tg anchorless), PrPSc is deposited not only in CNS and lymphoid tissues, but also in extraneural tissues including heart, brown fat, white fat, and colon. In the present paper, we report ultrastructural studies of amyloid PrPSc deposition in extraneural tissues of scrapie-infected tg anchorless mice. Amyloid PrPSc fibrils identified by immunogold-labeling were visible at high magnification in interstitial regions and around blood vessels of heart, brown fat, white fat, colon, and lymphoid tissues. PrPSc amyloid was located on and outside the plasma membranes of adipocytes in brown fat and cardiomyocytes, and appeared to invaginate and disrupt the plasma membranes of these cell types, suggesting cellular damage. In contrast, no cellular damage was apparent near PrPSc associated with macrophages in lymphoid tissues and colon, with enteric neuronal ganglion cells in colon or with adipocytes in white fat. PrPSc localized in macrophage phagolysosomes lacked discernable fibrils and might be undergoing degradation. Furthermore, in contrast to wild-type mice expressing GPI-anchored PrP, in lymphoid tissues of tg anchorless mice, PrPSc was not associated with follicular dendritic cells (FDC), and FDC did not display typical prion-associated pathogenic changes.
引用
收藏
页码:234 / 248
页数:15
相关论文
共 33 条
  • [1] The sheddase ADAM10 is a potent modulator of prion disease
    Altmeppen, Hermann C.
    Prox, Johannes
    Krasemann, Susanne
    Puig, Berta
    Kruszewski, Katharina
    Dohler, Frank
    Bernreuther, Christian
    Hoxha, Ana
    Linsenmeier, Luise
    Sikorska, Beata
    Liberski, Pawel P.
    Bartsch, Udo
    Saftig, Paul
    Glatzel, Markus
    [J]. ELIFE, 2015, 4 : 1 - 50
  • [2] Prion-associated dilated cardiomyopathy
    Ashwath, ML
    DeArmond, SJ
    Culclasure, T
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (03) : 338 - 340
  • [3] NEARLY UBIQUITOUS TISSUE DISTRIBUTION OF THE SCRAPIE AGENT PRECURSOR PROTEIN
    BENDHEIM, PE
    BROWN, HR
    RUDELLI, RD
    SCALA, LJ
    GOLLER, NL
    WEN, GY
    KASCSAK, RJ
    CASHMAN, NR
    BOLTON, DC
    [J]. NEUROLOGY, 1992, 42 (01) : 149 - 156
  • [4] GENETIC-CONTROL OF AMYLOID PLAQUE PRODUCTION AND INCUBATION PERIOD IN SCRAPIE-INFECTED MICE
    BRUCE, ME
    DICKINSON, AG
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1985, 44 (03) : 285 - 294
  • [5] NEUROPATHOLOGICAL DIAGNOSTIC-CRITERIA FOR CREUTZFELDT-JAKOB-DISEASE (CJD) AND OTHER HUMAN SPONGIFORM ENCEPHALOPATHIES (PRION DISEASES)
    BUDKA, H
    AGUZZI, A
    BROWN, P
    BRUCHER, JM
    BUGIANI, O
    GULLOTTA, F
    HALTIA, M
    HAUW, JJ
    IRONSIDE, JW
    JELLINGER, K
    KRETZSCHMAR, HA
    LANTOS, PL
    MASULLO, C
    SCHLOTE, W
    TATEISHI, J
    WELLER, RO
    [J]. BRAIN PATHOLOGY, 1995, 5 (04) : 459 - 466
  • [6] Review: Cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy
    Carare, R. O.
    Hawkes, C. A.
    Jeffrey, M.
    Kalaria, R. N.
    Weller, R. O.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 (06) : 593 - 611
  • [7] N-TERMINAL TRUNCATION OF THE SCRAPIE-ASSOCIATED FORM OF PRP BY LYSOSOMAL PROTEASE(S) - IMPLICATIONS REGARDING THE SITE OF CONVERSION OF PRP TO THE PROTEASE-RESISTANT STATE
    CAUGHEY, B
    RAYMOND, GJ
    ERNST, D
    RACE, RE
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (12) : 6597 - 6603
  • [8] Anchorless prion protein results in infectious amyloid disease without clinical scrapie
    Chesebro, B
    Trifilo, M
    Race, R
    Meade-White, K
    Teng, C
    LaCasse, R
    Raymond, L
    Favara, C
    Baron, G
    Priola, S
    Caughey, B
    Masliah, E
    Oldstone, M
    [J]. SCIENCE, 2005, 308 (5727) : 1435 - 1439
  • [9] Fatal Transmissible Amyloid Encephalopathy: A New Type of Prion Disease Associated with Lack of Prion Protein Membrane Anchoring
    Chesebro, Bruce
    Race, Brent
    Meade-White, Kimberly
    LaCasse, Rachel
    Race, Richard
    Klingeborn, Mikael
    Striebel, James
    Dorward, David
    McGovern, Gillian
    Jeffrey, Martin
    [J]. PLOS PATHOGENS, 2010, 6 (03)
  • [10] Selective expression of prion protein in peripheral tissues of the adult mouse
    Ford, MJ
    Burton, LJ
    Morris, RJ
    Hall, SM
    [J]. NEUROSCIENCE, 2002, 113 (01) : 177 - 192